icon-menu
DONATE JOIN
Home
Clinical Guidance
Access resources to provide clinical care according to the best available evidence.
header image
We regularly develop methodologically rigorous, evidence-based clinical guidance based on existing medical literature and best practice. They should not be construed as prescribing exclusive courses of treatment or procedures relating to any clinical matter. We revise this guidance as needed. We also endorse guidelines produced by others if the guidance meets our rigorous standards.

Clinical Guidance

Produced
Society of Family Planning Committee Statement: Abortion nomenclature
READ THE RECOMMENDATION
Endorsed
Medication abortion with misoprostol-only: A sample protocol
READ THE RECOMMENDATION
Produced
Society of Family Planning clinical recommendation: Emergency contraception
READ THE RECOMMENDATION
Endorsed
Updated Mifepristone REMS requirements
READ THE RECOMMENDATION
Endorsed
Clinical considerations for management of severe complications when abortion care is restricted
READ THE RECOMMENDATION
Produced
Society of Family Planning committee consensus on Rh testing in early pregnancy
READ THE RECOMMENDATION
Endorsed
SMFM Consult Series #63: Cesarean scar ectopic pregnancy
READ THE RECOMMENDATION
Produced
Society of Family Planning clinical recommendation: Extended use of long-acting reversible contraception
READ THE RECOMMENDATION
Produced
Society of Family Planning interim clinical recommendations: Self-managed abortion
READ THE RECOMMENDATION
Endorsed
Recommendations for standardization of bleeding data analysis in contraceptive studies
READ THE RECOMMENDATION
Produced
Society of Family Planning clinical recommendations: Contraception and abortion care for persons who use substances
READ THE RECOMMENDATION
Produced
Society of Family Planning clinical recommendations: Contraceptive care in the context of pandemic response
READ THE RECOMMENDATION
Produced
Society of Family Planning committee consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC)
READ THE RECOMMENDATION
Produced
Committee statement on IUD nomenclature
READ THE RECOMMENDATION
Co-Produced
SMFM Consult Series #59, The use of analgesia and anesthesia for maternal-fetal procedures
READ THE RECOMMENDATION
Produced
Pain control in surgical abortion part 2 – moderate sedation, deep sedation, and general anesthesia
READ THE RECOMMENDATION
Produced
Management of individuals with bleeding or thrombotic disorders undergoing abortion
READ THE RECOMMENDATION
Endorsed
SMFM Consult Series #55: Counseling women at increased risk of maternal morbidity and mortality
READ THE RECOMMENDATION
Co-Produced
Medication abortion up to 70 days of gestation
READ THE RECOMMENDATION
Produced
Contraceptive counseling for transgender and gender diverse people who were female sex assigned at birth
READ THE RECOMMENDATION
Produced
Cervical preparation for dilation and evacuation at 20–24 weeks’ gestation
READ THE RECOMMENDATION
Co-Produced
Reproductive services for women at high risk for maternal mortality: A report of the workshop of the Society for Maternal-Fetal Medicine, the American College of Obstetricians and Gynecologists, the Fellowship in Family Planning, and the Society of Family Planning
READ THE RECOMMENDATION
Endorsed
Online Training: Medication Abortion in Primary Care
READ THE RECOMMENDATION
Co-Produced
Consensus guidelines for facilities performing outpatient procedures: Evidence over ideology
READ THE RECOMMENDATION
Co-Produced
The importance of access to comprehensive reproductive health care, including abortion: A statement from women’s health professional organizations
READ THE RECOMMENDATION
Produced
Contraception after surgical abortion
READ THE RECOMMENDATION
Produced
Pain control in surgical abortion part 1 — local anesthesia and minimal sedation
READ THE RECOMMENDATION
Produced
Postplacental insertion of intrauterine devices
READ THE RECOMMENDATION
Produced
Use of intrauterine devices in nulliparous women
READ THE RECOMMENDATION
Produced
Medical abortion reporting of efficacy: The MARE guidelines
READ THE RECOMMENDATION
Produced
Cervical dilation before first-trimester surgical abortion (<14 weeks' gestation)
READ THE RECOMMENDATION
Produced
Cervical preparation for second-trimester surgical abortion prior to 20 weeks’ gestation
READ THE RECOMMENDATION
Produced
Interruption of nonviable pregnancies of 24–28 weeks’ gestation using medical methods
READ THE RECOMMENDATION
Produced
Surgical abortion prior to 7 weeks of gestation
READ THE RECOMMENDATION
Endorsed
Second-trimester abortion
READ THE RECOMMENDATION
Produced
Management of postabortion hemorrhage
READ THE RECOMMENDATION
Produced
First-trimester abortion in women with medical conditions
READ THE RECOMMENDATION
Produced
Cancer and contraception
READ THE RECOMMENDATION
Produced
Labor induction abortion in the second trimester
READ THE RECOMMENDATION
Produced
Prevention of infection after induced abortion
READ THE RECOMMENDATION
Produced
Induction of fetal demise before abortion
READ THE RECOMMENDATION
Clinical Affairs Committee

The Society’s Clinical Affairs Committee oversees clinical guidance by prioritizing topics, selecting authors, and reviewing and approving each document before it is submitted for publication in Contraception.

Author Instructions

The Clinical Affairs Committee’s procedures and the types of clinical guidance produced by the Society is available in our author instructions.

Connect

Suggest a topic for new clinical guidance.

Graphic

Rh testing and administration is no longer recommended prior to 12 weeks gestation for patients undergoing spontaneous, medication, or procedural abortion.